Covered recipient · General Payments record
MADELAINE FELDMAN
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$57,091.26
- Reported across 438 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $4,065.00 | 2 |
| Travel and Lodging | $1,091.82 | 4 |
| Food and Beverage | $867.12 | 35 |
| Education | $77.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $2,782.30 | 5 |
| Aurinia Pharma U.S., Inc. | $1,440.87 | 2 |
| PFIZER INC. | $1,042.75 | 5 |
| Amgen Inc. | $299.67 | 6 |
| ABBVIE INC. | $168.31 | 10 |
| Janssen Biotech, Inc. | $123.50 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $71.49 | 3 |
| GENZYME CORPORATION | $55.18 | 2 |
| E.R. Squibb & Sons, L.L.C. | $35.57 | 2 |
| Johnson & Johnson Health Care Systems Inc. | $32.15 | 1 |
| GlaxoSmithKline, LLC. | $29.31 | 2 |
| Genentech USA, Inc. | $20.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (42)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.56 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718498 | CMS |
| ABBVIE INC. | $6.13 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718500 | CMS |
| ABBVIE INC. | $3.69 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718502 | CMS |
| ABBVIE INC. | $23.87 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718504 | CMS |
| ABBVIE INC. | $14.43 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718506 | CMS |
| ABBVIE INC. | $25.56 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718508 | CMS |
| ABBVIE INC. | $11.32 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718510 | CMS |
| ABBVIE INC. | $18.90 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718512 | CMS |
| ABBVIE INC. | $21.15 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718514 | CMS |
| ABBVIE INC. | $27.70 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103718516 | CMS |
| Amgen Inc. | $26.84 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111573426 | CMS |
| Amgen Inc. | $10.31 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111573422 | CMS |
| Amgen Inc. | $19.72 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111573420 | CMS |
| Amgen Inc. | $27.74 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111573424 | CMS |
| Amgen Inc. | $101.82 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111573428 | CMS |
| Amgen Inc. | $113.24 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117552267 | CMS |
| Aurinia Pharma U.S., Inc. | $15.87 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150680007 | CMS |
| Aurinia Pharma U.S., Inc. | $1,425.00 | 02/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150680009 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.50 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101306769 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.07 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101306823 | CMS |
| Genentech USA, Inc. | $20.83 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133057629 | CMS |
| GENZYME CORPORATION | $27.08 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139880361 | CMS |
| GENZYME CORPORATION | $28.10 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139880377 | CMS |
| GlaxoSmithKline, LLC. | $14.77 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116713055 | CMS |
| GlaxoSmithKline, LLC. | $14.54 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116346806 | CMS |
| Janssen Biotech, Inc. | $77.99 | 05/21/2024 | Education | Undisputed | 01/23/2026 | 1078677054 | CMS |
| Janssen Biotech, Inc. | $13.73 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078676928 | CMS |
| Janssen Biotech, Inc. | $31.78 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078676798 | CMS |
| Johnson & Johnson Health Care Systems Inc. | $32.15 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077572884 | CMS |
| Novartis Pharmaceuticals Corporation | $15.83 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086852315 | CMS |
| Novartis Pharmaceuticals Corporation | $24.33 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086852319 | CMS |
| Novartis Pharmaceuticals Corporation | $31.33 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086852323 | CMS |
| PFIZER INC. | $4.80 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130972802 | CMS |
| PFIZER INC. | $12.61 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130973383 | CMS |
| PFIZER INC. | $13.21 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132051848 | CMS |
| PFIZER INC. | $452.44 | 12/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1131599891 | CMS |
| PFIZER INC. | $559.69 | 12/17/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1131229118 | CMS |
| UCB, Inc. | $38.29 | 05/29/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143470021 | CMS |
| UCB, Inc. | $41.40 | 05/29/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143470026 | CMS |
| UCB, Inc. | $2,640.00 | 05/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1143470030 | CMS |
| UCB, Inc. | $26.94 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143470035 | CMS |
| UCB, Inc. | $35.67 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143470039 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.